Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infections

Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infections

Bibliographic Details
Main Authors: Kresken, Michael, von Müller, Lutz, Grabein, Béatrice, Herrmann, Mathias, Höffken, Gert, Hoerauf, Achim, Kern, Peter, Pletz, Mathias W., Reisinger, Emil, Cornely, Oliver A., Groll, Andreas H.
Format: Article
Language:English
Published: German Medical Science GMS Publishing House 2013-11-01
Series:GMS Infectious Diseases
Online Access:http://www.egms.de/static/en/journals/id/2013-1/id000007.shtml

Internet

http://www.egms.de/static/en/journals/id/2013-1/id000007.shtml

Similar Items